Featured News

Congress passed and on May 5th, the President signed the Consolidated Appropriations ACT for Fiscal Year 2017, which includes a $10 million line item for kidney cancer research under the Congressionally Directed Medical Research Programs (CDMRP). This represents the largest increase ever in the federal budget for kidney cancer research. Kidney cancer strikes 64,000 Americans each year, and over 14,400 succumb to the disease. The $10 million will provide a shot in the arm to… More →



Smoking and Election Day

by Jay Bitkower on December 26, 2016

Election Day was also a day in which four states have referendums on raising their taxes on cigarettes: Colorado, California, Missouri, and North Dakota. Below, we’ll look at the tax proposals, arguments for and against, campaign spending and the groups behind them, and the results of the voting. Much of the voting information is extracted from the Ballotpedia website. According to the Centers for Disease Control, over 480,000 Americans die from diseases caused by cigarette… More →



Federal Funding for Cancer

by Jay Bitkower on December 1, 2016

We did an analysis of the U.S Federal funding for the top 18 cancer types as a ratio of dollars spent versus the cancer type’s incidence and mortality rates.  For dollars spent per incidence, brain cancer came out on top at $7,686 per incidence, followed by ovarian ($5,010) and leukemia ($4,545). Kidney cancer was in 14th place at $613 per incidence. For dollars spent per mortality, breast cancer came out on top at $15,842 per mortality… More →



AUA Investigator Article

by Jay Bitkower on November 29, 2016

ACKC VP Fred Atkin authored an article for the Fall edition of the American Urological Association’s AUA Investigator:     Action to Cure Kidney Cancer (ACKC) is a nonprofit organization that advocates for increased federal and private funding for kidney cancer research. Thanks to their most recent advocacy efforts, the House passed the FY2017 Defense Appropriations bill, which includes a $10 million budgeted line item designated solely for kidney cancer research under the Congressionally Directed Medical… More →



After years of advocacy emphasizing the lack of kidney cancer federal funding, on Tuesday, May 17th, the House Appropriations Committee approved the FY17 Defense Appropriations Act and forwarded the bill to the full House.  The fiscal year 2017 Defense appropriations bill includes a $10 million line item within the Defense Health Program, Congressional Directed Medical Research Program for kidney cancer research. This is great news for the kidney cancer community. If this legislation is enacted,… More →